Maple Rock Capital Partners Inc. Has $123.93 Million Stake in CVS Health Corporation $CVS

Maple Rock Capital Partners Inc. grew its holdings in CVS Health Corporation (NYSE:CVS) by 14.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,197,996 shares of the pharmacy operator’s stock after purchasing an additional 149,896 shares during the period. CVS Health makes up about 2.5% of Maple Rock Capital Partners Inc.’s portfolio, making the stock its 13th biggest position. Maple Rock Capital Partners Inc. owned about 0.09% of CVS Health worth $123,933,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Kilter Group LLC acquired a new position in CVS Health in the 2nd quarter worth about $27,000. Beaird Harris Wealth Management LLC grew its holdings in CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the last quarter. J.Safra Asset Management Corp acquired a new position in CVS Health in the 2nd quarter valued at approximately $30,000. Dunhill Financial LLC acquired a new position in shares of CVS Health during the second quarter worth $32,000. Finally, Swiss RE Ltd. bought a new stake in shares of CVS Health in the fourth quarter worth $26,000. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on CVS. Bank of America increased their price objective on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Weiss Ratings upgraded CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. UBS Group increased their price target on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Morgan Stanley raised their price objective on CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a research report on Thursday, June 4th. Finally, JPMorgan Chase & Co. upped their target price on CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Performance

Shares of CVS opened at $94.02 on Tuesday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $101.27 and its two-hundred day simple moving average is $89.68. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The stock has a market capitalization of $120.25 billion, a P/E ratio of 24.87, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the company posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.8%. CVS Health’s payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.